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a b s t r a c t
Snake venom L-amino acid oxidase (SV-LAAO, a ﬂavor-enzyme) has attracted considerable attention
due to its multifunctional nature, which is manifest in diverse clinical and biological effects such as
inhibition of platelet aggregation, induction of cell apoptosis and cytotoxicity against various cells. The
majority of these effects are mediated by H2O2 generated during the catalytic conversion of L-amino
acids. The substrate analog L-propargylglycine (LPG) irreversibly inhibited the enzyme from Crotalus
adamanteus and Crotalus atrox in a dose- and time-dependent manner. Inactivation was irreversible
which was signiﬁcantly protected by the substrate L-phenylalanine. A Kitz–Wilson replot of the in-
hibition kinetics suggested formation of reversible enzyme–LPG complex, which occurred prior to
modiﬁcation and inactivation of the enzyme. UV–visible and ﬂuorescence spectra of the enzyme and
the cofactor strongly suggested formation of covalent adduct between LPG and an active site residue
of the enzyme. A molecular modeling study revealed that the FAD-binding, substrate-binding and the
helical domains are conserved in SV-LAAOs and both His223 and Arg322 are the important active site
residues that are likely to get modiﬁed by LPG. Chymotrypsin digest of the LPG inactivated enzyme fol-
lowed by RP-HPLC and MALDI mass analysis identiﬁed His223 as the site of modiﬁcation. The ﬁndings
reported here contribute towards complete inactivation of SV-LAAO as a part of snake envenomation
management.
C© 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY-NC-ND license.Fig. 1. Catalytic oxidation of l-amino acid oxidase. The ﬁrst half reaction involves the
conversion of FAD to FADH2 with concomitant oxidation of the amino acid to an imino
acid. Another oxidative half reaction completes the catalytic cycle by reoxidizing the
FADH2 with oxygen, producing hydrogen peroxide. The unstable imino acid is then
hydrolyzed by the enzyme bound water to form the ﬁnal product keto acid.1. Introduction
l-amino acid oxidase (LAAO), a dimeric enzyme containing non-
covalently bound FAD as cofactor, is widely present in eukaryotic
and prokaryotic organisms [1]. They catalyse stereospeciﬁc oxidative
deamination of l-amino acids to α-keto acid via α-imino acid inter-
mediate along with generation of ammonia and hydrogen peroxide
(Fig. 1). These enzymes exhibit a marked preference for hydrophobic
amino acids like phenylalanine, tryptophan, tyrosine and leucine as
substrate [2,3]. This substrate preference originates from the binding
of hydrophobic side chains of amino acidswith the enzyme. The catal-
ysis is proposed to follow either of the two different mechanisms: a
carbanion pathway in which the proton is transferred to the FMN/Abbreviations: CHD, 1,2-cyclohexanedione; DEPC, diethylpyrocarbonate; FAD,
ﬂavinadeninedinucleotide;Gdn-HCl, guanidinehydrochloride; LAAO, l-aminoacidox-
idase (EC. 1.4.3.2); LPG, l-propargylglycine; l-Phe, l-phenylalaine;MALDI-TOF,matrix-
assisted laser desorption ionization-time of ﬂight; TNBS, trinitrobenzene sulfonic acid.
* Corresponding author. Tel.: +91 33 2499 5764; fax: +91 33 2473 5197.
E-mail address: debasish@iicb.res.in (D. Bhattacharyya).
2211-5463 c© 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of Europe
http://dx.doi.org/10.1016/j.fob.2013.01.010FAD cofactor from the α-carbon atom of the substrate leaving a neg-
ative charge followed by two electron transfer. Alternately, a hydride
transfer pathway inwhich an alpha hydrogen atom is transferred as a
hydride ion carrying two electrons simultaneously. Recent structural
andmechanistic studies on d-amino acid oxidase (DAAO) support the
hydride transfer mechanism [4].
LAAOs isolated from snake venoms are the best characterized
members of this enzyme family. High abundance of the enzyme inan Biochemical Societies. Open access under CC BY-NC-ND license.
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Fig. 2. (A) Time course of oxidation of (a) 62.5, (b) 125, (c) 250, (d) 375 and (e) 500
μM of LPG by 81.22 nM of LAAO. Experimental conditions have been mentioned in the
text. (B) Linear dependence of the initial rate and (C) product formation at 180 min,
when the reactions was assumed to be complete with the concentration of LPG. R2
(regression coefﬁcient) values are 0.992 and 0.996, respectively.nake venom causes potential toxicity, as it induces impairment of
latelet aggregation together with necrotic and apoptotic cell death
2,5,6]. This effect is primarily attributed to the production of high
oncentration of localized H2O2 [7,8]. LAAO from Crotalus adaman-
eus and Crotalus atrox can associate speciﬁcally with mammalian
ndothelial cells possibly through the glycosylation site of the en-
yme [7,9]. Such association and interaction of LAAO with bacterial
ell was observed in case of Trichoderma harzianum ETS323 [10]. It
s predicted that the glycan moiety of LAAO is used in docking the
nzyme to the cell surface, thus enhancing the localization of H2O2
7,9]. This enzyme share sequence similaritywith humanmonoamine
xidase (MAO) and may involved in allergic inﬂammatory response
11]. Recent crystallographic studies of LAAO from Calloseasma rho-
ostoma complexed with l-Phe and o-aminobenzoic acid reveal that
he catalytic site of each subunit of the dimeric enzyme is composedof
hree parts: a FAD-binding domain, a substrate-binding domain and
helical domain [12,13]. High degree of structural similarity of these
hree domains of LAAO from C. rhodostoma, Bothrops jararacussu and
othrops moojeni was observed through comparative sequence ho-
ology and molecular modeling [14]. Also LAAO from C. rhodostoma
hares 83% sequence identity with that of both C. adamanteus and C.
trox. Overall, snake venom LAAOs are highly conserved with respect
o their structure, function and substrate speciﬁcity.
A variety of mechanism based inhibitors have been reported for a
umber of ﬂavoenzymes [15,16]. These inhibitors can inactivate the
nzymes either by modifying the cofactor or a reactive amino acid
esidue during catalytic turnover [17–24]. Success of such inhibitors
as generated an increasing interest towards designing of suicidal
ubstrate for LAAO for partial neutralization of venom toxicity. Ear-
ier reports indicate that l-propargylglycine (LPG) acts as a substrate
f lower afﬁnity and not an inhibitor of LAAO from C. adamanteus
hereas d-propargylglycine acts as an inhibitor of d-amino acid ox-
dase (DAAO) [25–27]. Inactivation of LAAO by LPG was not realized,
ither due to the low concentration of LPG applied or the kinetic of
nactivation was followed for a short time. Here, we report that LPG
rreversibly inactivates LAAO by modifying active site His223 during
ts catalytic turnover. Thus it acts as a mechanism-based inhibitor.
imilar results were also observed with LAAO from C. atrox venom.
The working hypothesis of the current observation is that there
remultiple substrate/inhibitor binding sites in the catalytic funnel of
AAO of which one is responsible for catalytic turnover. It is believed
hat LPG at low concentration binds exclusively at the catalytic site
nd undergoes enzymatic conversion. But at higher concentration,
PGbinds atmultiple sites including the catalytic site of LAAO.Binding
f LPG at noncatalytic sites probably induces conformation change of
he enzyme that leads to covalent modiﬁcation of the enzyme with
PG undergoing conversion at the catalytic site leading to a dead end
omplex. This assumption is based on the crystal structures of LAAOs
here existence of multiple substrate/inhibitor binding sites in the
atalytic funnel is evident [12,13]. The purpose of this study is to gain
nsight for designing speciﬁc and potent inhibitors of LAAO.
. Results
.1. Oxidation of LPG by LAAO
Unless mentioned otherwise, LAAO used in this work refers to the
nzyme from C. adamanteus. LPG, a propargyl derivative of l-glycine
as all the features that are essential for becoming a substrate of
AAO, e.g., amino and carboxylic groups along with a hydrophobic
ide chain. LPG up to 500 μM acts as a substrate of LAAO for at least
80minwhenmonitored at 320 nm (Fig. 2A). The initial rates and the
mounts of product formed by180 min when it is assumed that the
eaction is complete, show linear dependencywith LPG concentration
Fig. 2B and C). Since no inactivation was observed during the course
f turnover, it is clear that irreversible enzyme–inhibitor adduct isnot formed under that concentration of LPG. Therefore, it is assumed
that the absorbance at 320 nm is exclusively contributed by the LPG
oxidation product 3-amino-5-methylene-5H-furan-2-one and not by
the adduct that also absorbs at 320 nm (discussed later).
In order to compare the afﬁnity of the substrates l-Phe and LPG,
Michaelis–Menten plots were constructed. While measuring the ini-
tial rates, the reactions were followed for 120 s where linear in-
crement of product formation was observed. Dependence of initial
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Fig. 3. Dependence of irreversible inactivation of LAAO on the concentration of LPG.
(a) Residual activity of LAAO after incubation with 0–25 mM of LPG at 4 ◦C for 24 h.
(b) Activity of the enzyme preparations of set (a) after passing through Sephadex G-50
‘Spin column’ to remove unreacted LPG and its catalytic products. (c) Activity of the
enzyme preparation of set (b) after incubation at 4 ◦C for 24 h allowing time dependent
dissociation of enzyme–inhibitor adduct, if any. Activity of the enzyme before passing
through ‘Spin-column’ is taken as 100%.
Fig. 4. Presentation of the mechanism of inactivation of LAAO, presented as E, by the
suicidal substrate LPG. The ratio kcat/kinact is deﬁne as the partition ratio and it denotes
the inhibitor potency of the inhibitor, as it express the extent of bifurcation of a reaction
towards product formation and inactivation.
Fig. 5. Protection of LAAO activity with concentration of l-Phe in presence of 25 mM
of LPG. Activity of the enzyme incubated with 0.38 mM l-Phe is considered as 100%.rates as a function of substrate concentration resulted in a rectangu-
lar hyperbolic proﬁle (Supplementary Fig. S1A and B). Correspond-
ing double reciprocal (Lineweaver–Burk) plots show good linearity
(Supplementary Fig. S1, insets). The kinetic parameter derived from
Michaelis–Menten plot showed that l-Phe (KM = 37.82 ± 2.82 μM,
kcat = 6.27 ± 0.1 s−1) is more susceptible to oxidation by LAAO than
LPG (KM = 7.95 ± 0.43 mM, kcat = 9.62 ± 0.18 s−1) (n = 4). However
l-glycine was not oxidized by LAAO (data not shown). These results
suggest that the propargyl group in LPG makes it a better substrate
than l-glycine but signiﬁcantly poorer as compared to l-Phe ( Table
1).
2.2. Irreversible inactivation of LAAO by LPG
Incubation of LAAO (0.5 U, 81.22 nM, 0.812 nmol) in presence of
25 mM LPG (25 μmol) at 30 ◦C for 2 h resulted in reduction of its
oxidase activity by >90%. An additional application of 25 mM of LPG
at the end of 2 h eventually led to complete inactivation of the en-
zyme by an hour. Under identical conditions and in absence of LPG,
the enzyme is inactivated at most by 10%. To exclude product inhibi-
tion, the oxidation products were isolated by ultraﬁltration through
30 kDa cut-off ﬁlter membranes and were incubated with LAAO. No
product inhibition was observed. Irreversible nature of the inhibition
was ascertained by incubating the enzyme in presence of 2.5–25 mM
of LPG at 4 ◦C for 24 h whereby the residual activity was reduced to
approximately 10%. The inactive enzyme was passed through 1-ml
Sephadex G-50 ‘Spin-column’ to remove excess inhibitor and the oxi-
dation products [28]. Oxidase activity was measured immediately by
taking an aliquot and rest of the sample was kept at 4 ◦C for 24 h
to allow slow dissociation of the enzyme–inhibitor complex, if any,
in absence of excess inhibitor. In either case, lost activities could not
be recovered. In absence of LPG, the enzyme was completely stable
(Fig. 3). This data suggest that the substrate analog LPG irreversibly
inhibits LAAO and that through nondissociable association. The situa-
tion that LPG acts as a substrate of LAAO and also irreversibly inhibits
LAAO has been schematically presented in Fig. 4.
2.3. Protection of inactivation by substrate
Incubation of LAAO with LPG at the same molar ratio as stated
above at 4 ◦C for 24 h resulted in 90% loss of activity. To determine
whether inactivation occurs during catalysis and at the active site, theincubationwas carried out in presence of 0–30mMof l-Phe substrate.
Activity of these enzyme preparationsweremeasured after extensive
dialysis at 4 ◦C. It was observed that with increasing concentration of
l-Phe, 90% of the enzyme activity could be protected (Fig. 5). This sug-
gests that LPG compete with the substrate l-Phe during inactivation
of LAAO.
2.4. Inactivation kinetics of LAAO with LPG
Irreversible inactivation of LAAOwas further analyzed after prein-
cubation of the ﬂavoenzyme with 5–25 mM of LPG, followed by dilu-
tion into assay buffer to determined residual activities. The enzyme
(0.5 U, 81.22 nM, 0.812 nmol) showed both concentration and time-
dependent inhibition with respect to LPG. The kinetics of inactivation
(kobs) was determined from the linear dependencies with logarithm
of percent residual activity (Fig. 6A). To determine the Kitz–Wilson
kinetic parameters, the observed rate constant at various inhibitor
concentrations were ﬁtted to Eq. (1) [29].
1
kObs
= 1
kinact
+ K I
kinact
(
1
[I ]
)
(1)
where KI is the apparent inhibitor concentration required to reach
half-maximal rate of inactivation, kinact is themaximal rate of enzyme
inactivation and [I] is inhibitor concentration. Kitz–Wilson replot of
the observed rate constants yielded kinact = 0.0925 ± 0.0025 min−1
and KI = 7.49 ± 0.46 mM. The straight line in Kitz–Wilson replot
intersects the ordinate at 10.82 min indicating formation of dissocia-
ble enzyme–inhibitor complex that occurs before inactivation (Fig.
6B). In case the line passes through the origin, that indicates absence
of a reversible complex formation and inactivation is a direct conse-
quence of enzyme inhibitor collision. This data suggest that LPG acts
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Table 1
Kinetic parameters of LAAO.
Venom source l-Phenylalanine l-Propargylglycine
kcat (s
−1)a KM (μM)a kcat (s−1) KM (mM) kinact (min−1)b KI (mM)b
C. adamanteus 6.27 ± 0.10 37.82 ± 2.82 9.62 ± 0.18 7.95 ± 0.43 0.0925 ± 0.0025 7.49 ± 0.465
C. atrox 6.78 ± 0.06 36.01 ± 1.50 7.75 ± 0.50 11.78 ± 2.44 0.0825 ± 0.0067 9.69 ± 1.22
a kcat and KM were obtained from Michaelis–Menten plot constructed from the initial kinetics of 120 s.
b kinact and KI were determined using Eq. (1) as described in the text.
Fig. 6. (A) Time dependent inactivation of LAAO with variable concentration of LPG at
30 ◦C. (B) Kitz–Wilson replot from the adjacent kinetic data correlating the inverse of
kobs with the inverse of LPG concentration.
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Fig. 7. (A) UV–visible spectra of FAD (13 μM) (—), LAAO dialyzed against buffer (- -
-), LAAO inactivated by LPG before (·····) and after dialysis (-·-·-). LAAO concentration
was 0.5 U/ml. (B) UV–visible spectra of apo-LAAO (—) and LPG inactivated apo-LAAO
(- - -). The later shows a distinct peak at 320 nm marked by arrow. (C) Emission and
(D) excitation spectra of FAD from control LAAO (—) and LPG inactivated LAAO (- - -).
These spectra are identical with that of reference FAD that had not been included for
clarity.s a mechanism-based inhibitor of LAAO. It may be noted that from
he KI predicted above, approximately 15 mM of LPG is needed for
omplete inactivation of LAAO whereas 25 mM of LPG is required. A
ossible explanation is, during irreversible modiﬁcation of LAAO, a
ortion of LPG acts as substrate leading to gradual decrease of LPG
oncentration affecting the kinetics of inactivation. Further, because
f irreversiblemodiﬁcation of the enzyme, concentration of active en-
yme decreases too with time leading to slower rate of inactivation.2.5. Spectral analysis of inactivated complex
LAAO after complete inactivation by LPGwas extensively dialyzed
to remove unreacted LPG and its oxidation products. Fig. 7A and B
shows the UV–visible spectra of the inactivated enzyme. The control
enzyme when dialyzed under identical conditions shows spectrum
that is similar to FAD in its oxidized form as reported earlier [31].
The inactivated enzyme shows the presence of an enzyme-bound
chromophore, which has strong absorbance between 300–400 nm.
To remove the chromophoric adduct from the enzyme, the complex
was denatured with 8 M Gdn-HCl to dissociate the adduct as well
as the ﬂavin and was followed by ultraﬁltration to remove the small
molecules [30]. The spectrum of the apoenzyme prepared from the
inactivated complex has a distinct absorption at 320 nm (Fig. 7B).
Similar observation was reported for oxidation of d-propargylglycine
by d-amino acid oxidase [27]. This indicates association of the chro-
mophore with enzyme’s active site residue and not with the cofactor.
The characteristic ﬂuorescence spectra of the released FAD was iden-
tical with the FAD released under similar condition from unmodiﬁed
enzyme and reference FAD (excitation spectra, em: 525 nm, ex: 300–
500 nm, Fig. 7C; emission spectra, ex: 450 nm, em: 480–550 nm,
Fig. 7D). The λmax,ex = 360 and 450 nm and the λmax,em = 525 nm
were identical for FAD released from LPG inactivated enzyme and
the control active enzyme. The spectral data collectively indicate that
inactivation of the enzyme by LPG is a consequence of covalent mod-
iﬁcation that does not affect the FAD cofactor.
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Fig. 8. (A) Sequence alignment of the catalytic region of LAAOs from different venom
source, indicating conserved positions of histidine and arginine residues (marked by
arrows). The FAD and substrate binding residues are highlighted in light black and blue
respectively while yellow shade represents both substrate and FAD binding residues.
(B) Homology model of C. adamanteus LAAO obtained from CPH model 3.0 online
server. The catalytic site residues have been shown and they are deeply buried within
the enzyme. (C) Molecular surface representation of LAAO is used to help visualization
of the catalytic funnel where LPG being docked at the position of normal substrate,
maintaining a distance of 3.5 A˚ between α-C atom of LPG (cyan) and ﬂavine (red). (D)
Stereo viewof the catalytic site of LAAO showing the environment of LPG. The substrate
LPG is shown in cyan and the FAD in yellow. His223 and Arg322 that are susceptible
to modiﬁcation are present in the side-chain binding sub-pocket and nearest to the
accetylenic moiety of LPG. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
Fig. 9. Residual activity of LAAO (%) after modiﬁcation with DEPC, CHD and TNBS in
presence and absence of l-Phe or LPG.2.6. Sequence analysis and modeling study
Multiple sequence alignment of LAAOs from C. adamanteus with
C. atrox, Agkistrodon halys, Vipera ammodytes ammodytes and C. rho-
dostoma using Clustal W2.1 showed high homology (>83% sequence
identity) (Fig. 8A). Homology models of LAAO from C. adamanteus
generated from ‘Swiss model’ and ‘CPH model’ servers were exactly
the same as visualized by structural alignment using PyMol software
[32]. Furthermore superimposition of these model with that of C.
rhodostoma LAAO crystal structure reveals high degree of structural
similarity between FAD-binding, substrate-binding and helical do-
mains of these proteins. Pawelek et al. [12] have shown that Arg90,
Glu209, His223, Asp224, Tyr372 and Gly464 are responsible for con-
tact with three o-aminobenzoate inhibitor molecules observed in the
catalytic funnel. These residues direct the access of the substrate to
the active site and they superimpose on the same residues of the
C. adamanteus LAAO model. These demonstrate similar catalytic site
orientation between C. adamanteus and C. rhodostoma LAAOs. So C.
adamanteus LAAO model was aligned with the crystal structure of
LAAO from C. rhodostoma (PDB ID: 2IID). Since, LPG acts as a substrate
of LAAO, it must transfer α-hydrogen atom to FAD analogous to l-Phe
reaction. So LPG was manually docked at the position of the bound
substrate l-Phe [13]. While docking, the spacial orientations of the
functional groups (amino and carboxyl group) and the α-carbon atom
were kept unaltered as that of l-Phe in C. rhodostoma LAAO crystal
structure (Fig. 8B). As predicted by Moustafa et al. [13] the amino
group and the carboxyl group of the substrate analog LPG are in a po-
sition to form H-bond with Gly464 and Arg90 respectively. The side
chain of the amino acid analog is extended away from the cofactor
and is accommodated in a sub-pocket composing Ile430, His223 and
Arg322 (Fig. 8D). Noteworthy observation is that His223 and Arg322
werewithin a distance of 3.7–7.0 A˚ from the C2 atomof the acetylenic
side chain of LPG and thus, they are prone to be modiﬁed by LPG.
2.7. Modiﬁcation reaction
Modiﬁcation of the histidine and arginine residues of LAAO by the
group speciﬁc reagents DEPC and CHD resulted in complete inacti-
vation (Fig. 9). This suggests that both of the residues are involved
in catalysis. Hydroxylamine, HCl treatment of the enzyme resulted
in loss of 60% of activity. So reversal of histidine modiﬁcation was
not performed. Complete protection of activity in case of histidine
modiﬁcation was observed in presence of 7.7 mM of l-Phe whereas
in presence of 1mMLPG, 15–20% activitywas protected. Insigniﬁcant
protection of activity was observed in case of arginine modiﬁcation.
Modiﬁcation of lysine residues by TNBS had no effect on enzyme
activity (Fig. 9). These results suggest that inactivation due to modiﬁ-
cation of active site residues can only be protected in case of histidine.
Also as the substrate protects inactivation of the enzyme by LPG, it
suggest a possible participation of His223 in the adduct formation.
2.8. Covalently modiﬁed of His-223
Covalent modiﬁcation of the enzyme by LPG occurs probably
through a nucleophilic attack by an active site residue of the en-
zyme to the C3 atom of LPG (Fig. 10). Intact mass of LAAO from C.
adamanteus was provided by MALDI-TOF MS as 57,476 ± 100 Da
(Supplementary Fig. S2). The enzyme inactivated by LPG is expected
to have a mass higher by 112 Da due to covalent adduct formation.
But, it could not be detected as the instrument has a 100 Da mass
tolerance in the Mw range used. The cofactor isolated from the active
and LPG inactivated enzyme showed an identical mass of 784 Da in
the negative ion mode (Supplementary Fig. S2, inset). This supports
the absorption and ﬂuorescence data presented before.
The covalent adduct so formed has strong absorption at 320 nm
due to the extended conjugated double bond structure (Fig. 10). This
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Fig. 10. Proposed mechanism to explain the catalytic and suicide inactivation path-
way of l-amino acid oxidase by LPG. LPG (1) is oxidised by LAAO to the acetylenic
imine intermediate (2). The intermediate (2) can rearranged to the allenic imine in-
termediate (3), which either cyclises through intramolecular nucleophilic attack to
give the product 3-amino-5-methylene-5H-furan-2-one (4) or undergo nucleophilic
attack by a nucleophile present at the active site of the enzyme to form the inactive
enzyme–inhibitor adduct (5).
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Fig. 11. (A) RP-HPLC chromatogram of chymotryptic digest of LAAO inactivated by
LPGmonitored at 220 nm. Inset. The same chromatogram of control LAAO (upper) and
that of LPG inactivated LAAO (lower) respectively monitored at 320 nm. The peak of Rt
29.4 min marked by arrow corresponds to the LPG modiﬁed peptide. (B) MALDI mass
spectrum showsm/z of 884.89 Da, which correspond to themodiﬁed peptide KH*DDIF
where * denotes LPG adduct. The MSMS spectrum of this marked peptide is shown in
Supplementary Fig. S4.ttribute made it possible to locate the residue in LAAO modiﬁed by
his inhibitor. LAAO, inactivated irreversibly by LPG, was extensively
ialysed and subjected to α-chymotrypsin digestion. Use of trypsin
s the protease for the identiﬁcation of the LPGmodiﬁed peptide was
nsuccessful (discussed later). Application of the digest to RP-HPLC
nder water–acetonitrile gradient led to separation of a number of
eptides when followed at 220 nm (Fig. 11). When the same chro-
atogram was followed at 320 nm, elution of a major sharp peak
f retention time (Rt) 29.4 min was observed (Fig. 11A, lower inset).
nder identical conditions of HPLC with a control digested sample,
o component with absorption at 320 nmwas eluted (Fig. 11A, upper
nset). The isolated peptide when subjected to MALDI mass analysis
ielded m/z of 884.89 Da ([M+H]+) (Fig. 11B). This peak has been as-
igned to the peptide KH*DDIF (773 Da + 112 Da for the LPG adduct
arked as *).MSMS analysis of this peptide showsmass ion of 166.22,
84.22, 385.93 and 499.34 Da which correspond to F, KH, HDD and
DDI peptide, respectively (Supplementary Fig. S3). Further, diges-
ion of the unmodiﬁed enzyme with chymotrypsin did not yield a
eptide of 884.89 Da. Also LAAO from C. atrox after inactivation by
PG and digestion by chymotrypsin showed a peak of Rt = 29.4 min
n RP-HPLC when followed at 320 nm and that also yieldedm/z value
f 884.89 Da in mass analysis (Supplementary Fig. S4). These results
ndicate thatmodiﬁcation by LPG involves His223 residue sparing the
AD moiety.
. Discussion
Substrate analogues as mechanism-based inhibitor have received
onsiderable interest for several ﬂavoenzymes as their catalytic site
ontain reactive ﬂavin in addition to functional amino acids [15,16].
rreversible inhibition of ﬂavoenzymes with acetylenic substrate
nalogs mostly reveals covalent adduct formation through N5 or C4a
tom of the isoalloxazine moiety of FAD or FMN [33–36]. In case of
AAO from C. adamanteus, LPG acts as a weak substrate at low con-
entration (Fig. 2A). However, at higher concentration it acts as an
rreversible inhibitor. Since the catalytic funnel has multiple sites to
ccommodate substrate/inhibitor molecules, it is expected that at
igh concentration of LPG, these sites get saturated [12,13]. Probablythis induces conformational change of the enzyme that allows cova-
lent interaction of the propargyl group with the nucleophilic amino
acid residues of LAAO (Fig. 3). The structure of LPG as compared to
the substrate l-Phe, indicates that it may act as an active site di-
rected inhibitor. It is clear that the said LAAO–LPG reversible complex
undergoes two simultaneous reactions. One of them leads to prod-
uct formation while the other leads to an inactive adduct (Fig. 4).
The nature of binding of LPG as inhibitor is covalent as the enzyme–
inhibitor adduct could not be dissociated from the inactive enzyme
after passing through ‘Spin-column’. Further, neither the enzyme–
inhibitor complex did undergo time dependent dissociation nor the
inhibitory moiety could be separated from the enzyme under dena-
turing conditions (Figs. 3 and 7).
It is interesting to note that up to 0.5 mM, LPG acts faithfully as a
substrate of LAAO and not as an inhibitor reﬂecting its predominance
substrate like character. The hydrophobicity imparted by the propar-
gyl group makes LPG a suitable substrate of LAAO. Though the KM
of LPG is 210 fold higher than l-Phe, Michaelis–Menten relation and
Lineweaver–Bark dependency were well followed (Supplementary
Fig. S1). So, at low concentration of LPG, the fate of the acetylenic
intermediate is to cyclise leading to product formation [26]. Then
Jyotirmoy Mitra, D. Bhattacharyya / FEBS Open Bio 3 (2013) 135–143 141the question arises, what promotes LPG to act as an inhibitor at 5–
25 mM? Similar requirement of high concentration of inhibitors for
effective inhibition is known for monomeric sarcosine oxidase [37].
The crystallographic structure of LAAO shows that its catalytic site is
funnel like where the substrate enters into a pocket and the products
leave through the other end [13]. The catalytic region has multiple
substrate binding sites of variable afﬁnities [12]. It is speculated that
at high concentration, these sites get saturated with LPG, which af-
fects the geometry of the catalytic funnel, leading to a decrease in the
distance between the catalytic site and the irreversible modiﬁcation
site. The modiﬁcation site is meant to be the sub-pocket of the en-
zyme where the side-chain of the substrate amino acid or the analog
is accommodated. His223, present in this sub-pocket, is believed to
interact with LPG (discussed below). The Kitz–Wilson replot also pre-
dicts formation of a reversible enzyme–inhibitor complex followed
by irreversible inactivation (Fig. 6). In presence of high concentration
of l-Phe, inactivation of LAAO by LPG is prevented by 90% indicating
competition between the substrate and the inhibitor (Fig. 5).
Based on the evidence presented here, duel character of LPG as
substrate and inhibitor can be predicted from the chemistry of the
reaction. In case of l-Phe, the oxidation product is an unstable α-
imino acid, which is hydrolyzed to α-keto acid. Spectroscopic and
mass data show that FAD of the LPG inactivated LAAO is in its oxi-
dized form whereas a covalent enzyme adduct is formed. Therefore,
an active site amino acid residue gets modiﬁed. The reaction of LPG
with LAAO is likely to proceed as described in Fig. 10. First, LPG (1)
is enzymatically converted to the acetylenic imine intermediate (2)
with concomitant reduction of FAD to FADH2 (resembling Fig. 1). Sec-
ond, (2) undergoes rearrangement to an allenic imine intermediate
(3). This intermediate (3) undergoes nucleophilic attack either by the
carboxyl group of LPG itself or a nucleophilic residue of the enzyme.
The former leads to product formation (4) through cyclisation [26]
while the later results in irreversible modiﬁcation of the enzyme (5)
similar to other mechanism-based inhibitions [38–42].
While supporting the proposed mechanism of inhibition, com-
parison of the structure of LAAOs from different venoms were done.
Complete conservation of the substrate and FAD binding domains of
LAAO from C. adamanteus with that of C. rhodostoma was observed
from sequence alignment and homology modeling (Fig. 8A and B).
The catalytic site of LAAO containing FAD is deeply buried in a 25 A˚
long funnel-like entrance within the enzyme body. The funnel wall
contains both hydrophilic and hydrophobic residues to guide the sub-
strate or its analogue in a way to place the α-C atom within an aver-
age of 3.5 A˚ from the ﬂavin N5 atom for an effective hydride transfer
[12,13,43]. The homology model was structurally aligned with the
crystal structure (PDB ID: 2IID) and LPG was manually aligned at the
position of l-Phemaintaining a distance of∼3.5 A˚ fromﬂavin N5 [13].
It was observed that the acetylenic side chain of LPG is within 3.7–7.0
A˚ from His223 and Arg322 resides located in the side chain bind-
ing sub-pocket (Fig. 8D). The imidazole N-atom of histidine is in the
deprotonated form (pKa ∼ 6.04) as the pH used for the inactivation
reaction was 7.5. The side chains of Arg and Lys have pKa of ∼12.48
and ∼10.79 respectively. So His223 seems to be in a better position
to form a covalent adduct with the LPG intermediate. Lys and Ser,
which are susceptible to such modiﬁcation are also present in the
catalytic funnel but are not suitable targets due to greater distances.
The role of His, presumably the 223 residue, in adduct formation was
veriﬁed from amino acid modiﬁcation reactions. Inactivation of the
enzyme after histidine and arginine modiﬁcation indicated involve-
ment of these residues at the catalytic site. In case of only histidine,
prevention of inactivation by the substrate supports that His223 as
the most probable target for LPG modiﬁcation.
Once conﬁrmed that FAD is not the site of modiﬁcation by LPG,
attempts were made for ﬁngerprinting of the inactive enzyme by
MALDI-MS after tryptic digestion. The result was compared with un-
treated LAAO. Unfortunately, peptide peaks of mass difference 112Da for the LPG modiﬁed fragment could not be detected with full
conﬁdence. This is possibly due to the low abundance of modiﬁed
peptide. In the amino acid sequence of LAAO, the K222–H223 and
K231–R232 bonds are resistant to trypsin digestion, due to modiﬁca-
tion of H223 and repeat basic amino acid sequence. Thus themodiﬁed
peptide should be conﬁned between K191 and K252 of 6821 Da. This
peptide may be too large for an efﬁcient ionization. So, a different
proteolytic enzyme was selected to identify the site of modiﬁcation.
The LAAO from both C. adamanteus and C. atroxwas inactivated with
LPG, dialyzed extensively and subjected to chymotrypsin digestion to
yield small peptides. The modiﬁed peptide was then puriﬁed using
RP-HPLC and ﬁnally sequence of the isolated peptide was ascertained
as KH*DDIF by mass analysis where * indicates LPGmodiﬁcation (Fig.
11A and B, Supplementary Figs. S3 and S4).
The ﬁnding that LPG is an irreversible inhibitor of LAAO shows a
direction for developing more potent inhibitors of the enzyme that is
required in snakebite management. Catabolism of free l-amino acids
in blood by LAAO after snake envenomation, particularly at the site
of bite, is the major route to peroxide generation that leads to cell
apoptosis and tissue damages. Hydrophobic amino acids content in
human blood plasma are in the range of 60–120 μMafter normal diet
which is far less than that required for the protection of LPG reaction
[44,45]. Compounds with similar structure as of LPG that have higher
kinact than kcat values would hold good therapeutic values for external
uses like topical applications at the site of envenomation.
4. Conclusion
Irreversible inactivation of snake venom LAAO could be achieved
in presence of relatively high concentration of LPG when it appears
that the inhibitor binds at multiple sites of the catalytic region. The
transfer of a α-hydrogen atom of the amino acid substrate, which ac-
tivates the functionally inactivate moiety present in such substrate,
is essential. An ideal suicidal substrate of LAAO analogous to LPG
should bind the catalytic site at low concentration and during catal-
ysis should favor the inactivation reaction far excess over product
formation. Finally, low toxicity of the inhibitor is a crucial factor for
its safe application.
5. Materials and methods
5.1. Materials
Lyophilized crude venom of C. adamanteus and C. atrox, FAD, l-
Phe, LPG, CHD, DEPC, TNBS, o-dianisidine and DEAE-cellulose, α-
chymotrypsinwere from Sigma, USA. Sephadex G-100 andG-50were
from Amersham Biosciences, Uppsala, Sweden. Horseradish peroxi-
dase (sp. act. 280 U/mg) was from Sisco Research Laboratories Ltd.,
Mumbai, India. All other reagents were of analytical grade and pur-
chased locally. LPG in powder formwas dried to constant weight and
weighed gravimetrically to form a working solution of 500 mM in
water.
5.2. Puriﬁcation of LAAO
See Supplementary material.
5.3. Assay of LAAO
The oxidation of l-Phe to the keto acid and H2O2 by LAAO was
followed by the coupling enzyme horseradish peroxidase (HRP) in
presence of the chromomphoric dye o-dianisidine [46,47]. The col-
ored product formed was followed continuously at 28 ◦C at ε436nm =
8310 M−1 cm−1. The assay mixture contained 70 μM of l-Phe, 350
mU of HRP, 10 μM of o-dianisidine and the volume was made up to
1-ml by 20mMNa-phosphate, pH 7.5 (Buffer A). Among hydrophobic
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[mino acids that act as good substrate of LAAO, l-Phe was selected
ecause the activity of crude venoms used was provided in terms of
onversion of l-Phe (0.5 U/mg of protein, Sigma). To confer unifor-
ity, all LAAO assay were done using l-Phe as substrate. One U of
AAO activity is deﬁned as the amount that oxidatively deaminates 1
mol of l-Phe/min at 25 ◦C.
It was reported that LPG acts as a substrate of LAAO and the
xidation product other than H2O2 was characterized (3-amino-5-
ethylene-5H-furan-2-one, ε320nm = 13,000 M−1 cm−1) [26]. For
valuating kinetic parameters, oxidation of LPG was directly mea-
ured at 320 nm under similar experimental conditions as stated
bove where ingredients of coupling assay were excluded. The alter-
ate assay protocol, where formation of H2O2 was measured using
oupled assay system, was not adapted since with progress of reac-
ion, the product/s interfered with the couple assay systemmaking it
ess sensitive and erroneous.
.4. Inactivation of LAAO by LPG
LPG acts both as a substrate and an irreversible inhibitor of LAAO.
n aliquot of LAAO (100 μl, 812.2 nM, 0.812 nmol) in buffer A was
ixed with 100 μl of LPG (ﬁnal concentration being 5–25 mM) and
ncubated at 28 ◦C. Aliquots of 20 μl were withdrawn at an interval
f 5 min and added to 980 μl of the LAAO assay mixture. The increase
n absorbance at 436 nm was monitored for 120 s at 28 ◦C.
.5. UV–visible and ﬂuorescence spectra
Enzyme–inhibitor complex was formed as follows: LAAO (0.5 U,
1.22 nM, 0.812 nmoles) and LPG (25 mM) was incubated at 4 ◦C
or 24 h in buffer A. The inactive enzyme was exhaustively dialyzed
gainst buffer A at 4 ◦C for 24 h to remove excess inhibitor and its ox-
dation products. UV–visible spectra of the dialysed sample between
00–700 nm were recorded. The dialyzed enzyme was concentrated
y passing through Microcon centrifugal ﬁlter (30 kDa cut off) and
ubsequently denatured by diluting with 8 M Gdn-HCl in buffer A.
he denatured enzyme was dialyzed against the same denaturant for
4 h to remove FAD (modiﬁed or unmodiﬁed) and the non-covalently
ound adduct, if any [30]. The procedure ensures dissociation and
emoval of FAD and adduct from the enzyme under denatured con-
ition. The absorption spectra of the enzyme inhibitor complex were
ecorded at 28 ◦C using an Analytik Jena Specord 200 spectropho-
ometer. The resulting apoenzymewas ﬁnally dialyzed against buffer
to remove the denaturant and UV–visible spectrum was recorded.
To isolate FAD from the LAAO, a portion of the enzyme preparation
fter denaturation with 8 M Gdn-HCl as described above was passed
hrough the same 30 kDa cut off ﬁlter. Fluorescence was recorded
sing a Hitachi F-7000 spectroﬂurimeter.
.6. Chemical modiﬁcations with group-speciﬁc reagents
For histidine modiﬁcation, the enzyme (0.5 U, 81.22 nM, 0.812
mol) was incubated with 0.5 mM DEPC in buffer A at 22 ◦C and the
esidual activity was measured by withdrawing aliquots after 5 min.
EPCwas freshlyprepared in absolute ethanol. ConcentrationofDEPC
as determined spectrophotometrically by reacting with 10 mM
istidine and monitoring the absorbance of N-carbethoxyhistidine
ε242nm = 3200 M−1 cm−1) [48]. Reversal of DEPC modiﬁcation was
one by 0.1 M hydroxylamine hydrochloride under identical condi-
ions for 30min. Argininemodiﬁcationwas performedwith 10mMof
reshly prepared CHD (in absolute ethanol) in presence of 50 mMNa-
orate buffer, pH 8.0 at 22 ◦C for 5 min [49]. For lysine modiﬁcation,
he enzyme was treated with 10 mM TNBS (from a stock in water) in
00 mM NaHCO3, pH 8.0 at 30
◦C for 5 min, passed through a 1 ml
ephadex G-50 ‘Spin-column’ and the residual activity wasmeasured
50,28]. In all modiﬁcation experiments, control sets were run wherethe same amount of solvent/water was added to the enzyme and the
activity was measured.
5.7. Digestion of LPG Inactive LAAO and separation of peptides
Control LAAO and LPG inactivated LAAO free from excess LPG and
its catalytic product was digested with α-chymotrypsin at a ratio
50:1(w/w) in 100 mM NH4HCO3 buffer pH 8.0 at 37
◦C for 18 h. The
digested peptide pool was lyophilised and dissolved in HPLC grade
water and ﬁltered through 0.22 μm ﬁlter. The peptides were then
separated by a Symmetry300 C18 RP-HPLC column (4.6 × 250 mm).
The column was pre-equilibrated with 0.1% (v/v) TFA in water (sol-
vent A). Elution was made by a linear gradient of 70% of solvent D
0.1% (v/v) TFA in acetonitrile over 40 min. Flow rate of 1 ml/min and
elution of peptides was followed at 220 and 320 nm and peptides
were collected manually and lyophilised for further analysis.
5.8. Mass analysis
The molecular mass of LAAO was determined using an Ap-
plied Biosystem 4800MALDI-TOF/TOF instrument under positive ion
modes. The puriﬁed enzyme was desalted with a C4 zip-tip cartridge
(Millipore). The salt free protein in 50% acetonitrile containing 0.1%
TFA and was applied to the MALDI plate along with the matrix α-
cyano-4-hydroxycinnamic acid (CHCA) (12 mg/ml in the same sol-
vent) at a ratio of 1:1 (v/v). The sample was dried at room tempera-
ture andmass spectrumwas recorded from the accumulation of 1000
single shots. For FAD, the protein was denatured, precipitated with
methanol/acetonitrile (1:1), vortexed and centrifuged to get a clear
supernatant. The supernatantwas dried, reconstitutedwith CHCA so-
lution and applied to the MALDI plate for mass determination using
the negative ion detectionmode. Protease digested peptides after RP-
HPLC was directly spotted on MALDI plate along with CHCA for mass
analysis.
5.9. Sequence analysis and modeling study
Amino acid sequence of LAAO from C. adamanteus (Eastern Dia-
mondback rattle snake) and C. atrox (Western Diamondback rattle
snake) were obtained from UniprotKB/Swiss-prot database (http:/
/www.uniprot.org) (protein database O93364 and P56742, respec-
tively). The sequences were aligned with that of other LAAOs such
as Agkistrodon halys (PDB ID: 1REO), Vipera ammodytes ammodytes
(PDB ID: 3KVE) and C. rhodostoma (PDB ID: 2IID) using ‘Clustal
W’ for homology determination (http://www.ebi.ac.uk/Tools/msa/
clustalw2). The protein structure of LAAO from C. adamanteus was
predicted fromhomologymodelingusing twodifferent servers, ‘Swiss
model’ (http://www.swissmodel.expasy.org) [51] and ‘CPH model’
(http://www.cbs.dtu.dk/services/CPHmodels) [52]usingAgkistrodon
halys (PDB ID: 1REO) as the reference structure. Visualization and
preparation of illustrations were done by PyMol software [32].
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